Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Poolbeg Pharma co-founder raise stake

(Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company. Friel, who co-founded Poolbeg, purchased the shares on Friday at an average price of 2.5p per share, for a total value of £100,000.

Following the transaction, Friel holds a total of 41.21m ordinary Poolbeg shares, representing approximately 5.91% of the company's issued share capital.

As of 1545 BST, Poolbeg shares were up 6.55% at 3.09p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Record (REC) Director name: Witte,Jan Amount purchased: 340,171 @ 54.41p Value: £185,087.04

Record (REC) Director name: Heading,Richard Amount purchased: 340,171 @ 54.41p Value: £185,087.04

Poolbeg Pharma (POLB) Director name: Friel,Cathal Amount purchased: 4,000,000 @ 2.50p Value: £100,000.00

Record (REC) Director name: Ayles,Kevin Amount purchased: 48,462 @ 54.41p Value: £26,368.17

Intercede Group (IGP) Director name: Leest ,Klaas van der Amount purchased: 12,450 @ 178.16p Value: £22,180.92

Experian (EXPN) Director name: DeRose,Kathleen Amount purchased: 480 @ $52.29 Value: $20,696.01

Molten Ventures (GROW) Director name: Zimmermann,Andrew Amount purchased: 5,871 @ 288.02p Value: £16,909.65

Experian (EXPN) Director name: DeRose,Kathleen Amount purchased: 320 @ $51.80 Value: $13,668.67

Intercede Group (IGP) Director name: Leest ,Klaas van der Amount purchased: 5,000 @ 178.80p Value: £8,940.00

Intercede Group (IGP) Director name: Leest ,Klaas van der Amount purchased: 5,000 @ 176.00p Value: £8,800.00

Molten Ventures (GROW) Director name: Zimmermann,Andrew Amount purchased: 1,047 @ 285.04p Value: £2,984.37

Ultimate Products (ULTP) Director name: Dent,Chris Amount purchased: 1,992 @ 50.18p Value: £999.54

Cranswick (CWK) Director name: Aldersley,Christopher Amount purchased: 3 @ 5,327.00p Value: £159.81

Spirent Communications (SPT) Director name: Bell,Paula Amount purchased: 65 @ 192.40p Value: £125.06

Top Director Sells

Costain Group (COST) Director name: Vaughan,Alex Amount sold: 241,639 @ 144.00p Value: £347,960.17

Bytes Technology Group (BYIT) Director name: Mudd,Sam Amount sold: 65,264 @ 499.94p Value: £326,278.89

Costain Group (COST) Director name: Vaughan,Alex Amount sold: 214,285 @ 142.00p Value: £304,284.69

Costain Group (COST) Director name: Willis,Helen Amount sold: 100,082 @ 142.00p Value: £142,116.44

Picton Property Income Ltd (PCTN) Director name: Morris ,Michael Amount sold: 142,225 @ 80.05p Value: £113,851.11

Bytes Technology Group (BYIT) Director name: Mudd,Sam Amount sold: 20,548 @ 499.94p Value: £102,727.06

Gaming Realms (GMR) Director name: Robert Green,Geoffrey Amount sold: 200,000 @ 51.36p Value: £102,720.00

Costain Group (COST) Director name: Willis,Helen Amount sold: 56,429 @ 144.00p Value: £81,257.76

Picton Property Income Ltd (PCTN) Director name: Morris ,Michael Amount sold: 92,909 @ 80.05p Value: £74,373.65

Share this article

Related Sharecast Articles

Director dealings: Essentra CEO raises stake
(Sharecast News) - Essentra revealed on Wednesday that chief execuitve Scott Fawcett had acquired 17,483 ordinary shares in the FTSE 250-listed hardware manufacturer.
Director dealings: AB Dynamics CEO snaps up shares
(Sharecast News) - AB Dynamics revealed on Tuesday that chief executive Sarah Matthews-DeMers had acquired 2,000 ordinar shares in the AIM-listed automotive testing and development solution supplier.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Bioventix chairman raises stake
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.